Company Profile
Since its foundation in 1997, GENESIS Pharma has been a leading biopharmaceutical company, headquartered in Greece. The company's consolidated turnover has reached €222,9 million in 2010.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
5-Azacytidine |
1,3,5-Triazin-2(1H)-one,4-amino-1-β-D-ribofuranosyl-;s-Triazin-2(1H)-one,4-amino-1-β-D-ribofuranosyl-;4-Amino-1-β-D-ribofuranosyl-1,3,5-triazin-2(1H)-one;Antibiotic U 18496;5-Azacytidine;U 18496;NSC 102816;Azacitidine;Azacytidine;NSC 103-627;5-AZCR;Mylosar;5-AC;WR 183027;5-AzaC;5-AZC;Ladakamycin;Ledakamycin;Vidaza;CC 486;5-Azacitidine;52934-49-3;292869-98-8 |
320-67-2 | Inquiry | |
Carbonic acid,lanthanum(3+) salt (3:2), hydrate (9CI) |
Carbonic acid,lanthanum(3+) salt (3:2),hydrate;Lanthanum carbonate (La2(CO3)3) hydrate;Lanthanum carbonate (2:3) hydrate;Lanthanum carbonate hydrate |
54451-24-0 | Inquiry | |
Cinacalcet |
1-Naphthalenemethanamine,α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-,(αR)-;(αR)-α-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethanamine;Cinacalcet;AMG 073;N-[(1R)-1-(1-Naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine;Parareg |
226256-56-0 | Inquiry | |
Doxorubicin hydrochloride |
5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-,hydrochloride (1:1),(8S,10S)-;Adriamycin,hydrochloride;5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,hydrochloride,(8S-cis)-;5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,hydrochloride,(8S,10S)-;Doxorubicin hydrochloride;Adriamycin;Adriacin;Adriblastina RD;Adriblastina;Adriblastin;ADR;DOX HCl;FI 6804;ADM hydrochloride;Hydroxydaunorubicin hydrochloride;FI 106;Adriablastina CS;Lipo-Dox;Adrosal;Ameisu hydrochloride;Myocet liposomal;Doxolipad;Caelyx pegylated liposomal;Doxorubicin-TEVA;Doxorubicin-LANS |
25316-40-9 | Inquiry | |
Interleukin1 receptor antagonist (human isoform x reduced),N2-L-methionyl- (9CI) |
Anakinra;Kineret;Unii-9013duq28k;Interleukin1 receptor antagonist (huMan isoforM x reduced),N2-L-Methionyl- (9CI);human interleukin-1 receptor antagonist (IL-1Ra) |
143090-92-0 | Inquiry | |
Lenalidomide |
2,6-Piperidinedione,3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-;3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione;3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione;Revimid;CC 5013;CDC 501;Lenalidomide;Revlimid;1-Oxo-4-amino-2-(2,6-dioxopiperidin-3-yl)isoindole;3-(4-Amino-1-oxoisoindolin-2-yl)piperidin-2,6-dione;ENMD 0997;IMiD 3;revlMiD;346670-73-3;443912-14-9;824975-68-0 |
191732-72-6 | Inquiry | |
Thalidomide |
1H-Isoindole-1,3(2H)-dione,2-(2,6-dioxo-3-piperidinyl)-;Phthalimide,N-(2,6-dioxo-3-piperidyl)-;2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione;K 17;Contergan;N-(2,6-Dioxo-3-piperidyl)phthalimide;Distaval;Kevadon;α-Phthalimidoglutarimide;α-(N-Phthalimido)glutarimide;3-Phthalimidoglutarimide;N-Phthaloylglutamimide;α-N-Phthalylglutaramide;Softenon;Thalidomide;Sedoval;Softenil;Quetimid;Talimol;(±)-Thalidomide;1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline;Thalomid;Celgene;Suaramide;Talinol;Neurosedyn;NSC 66847;Sedalis;Pantosediv;NSC 527179;Myrin;Sauramide;Pharmion;Thaled;Synovir;N-(2,6-Dioxo-3-piperidinyl)phthalimide;Immunoprin;2-(2,6-Dioxopiperidin-3-yl)isoindoline-1,3-dione;2-(2,6-Dioxopiperidin-3-yl)isoindole-1,3-dione;2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione;2-(2,6-Dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione;731-40-8;14088-68-7 |
50-35-1 | Inquiry |
CONTACT INFORMATION
Sign In for Details